Literature DB >> 15229411

Update: influenza activity--United States and worldwide, 2003-04 season, and composition of the 2004-05 influenza vaccine.

.   

Abstract

During the 2003-04 influenza season, influenza A (H1), A (H3N2), and B viruses co-circulated worldwide, and influenza A (H3N2) viruses predominated. Several Asian countries reported widespread outbreaks of avian influenza A (H5N1) among poultry. In Vietnam and Thailand, these outbreaks were associated with severe illnesses and deaths among humans. In the United States, the 2003-04 influenza season began earlier than most seasons, peaked in December, was moderately severe in terms of its impact on mortality, and was associated predominantly with influenza A (H3N2) viruses. This report 1) summarizes information collected by World Health Organization (WHO) and National Respiratory and Enteric Virus Surveillance System (NREVSS) collaborating laboratories, state and local health departments, health-care providers, vital statistics registries, and CDC and 2) describes influenza activity in the United States and worldwide during the 2003-04 influenza season and the composition of the 2004-05 influenza vaccine.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15229411

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  58 in total

1.  Structural analysis of the hemagglutinin from the recent 2013 H7N9 influenza virus.

Authors:  Hua Yang; Paul J Carney; Jessie C Chang; Julie M Villanueva; James Stevens
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

2.  Detection of Avian Influenza A(H7N2) Virus Infection Among Animal Shelter Workers Using a Novel Serological Approach-New York City, 2016-2017.

Authors:  Eugenie Poirot; Min Z Levine; Kate Russell; Rebekah J Stewart; Justine M Pompey; Sophia Chiu; Alicia M Fry; Liaini Gross; Fiona P Havers; Zhu-Nan Li; Feng Liu; Aldo Crossa; Christopher T Lee; Vanessa Boshuizen; Jennifer L Rakeman; Sally Slavinski; Scott Harper; L Hannah Gould
Journal:  J Infect Dis       Date:  2019-05-05       Impact factor: 5.226

3.  Using Influenza-Like Illness Data to Reconstruct an Influenza Outbreak.

Authors:  Philip Cooley; Laxminarayana Ganapathi; George Ghneim; Scott Holmberg; William Wheaton
Journal:  Math Comput Model       Date:  2008

4.  Efficacy of the influenza vaccine in patients with malignant lymphoma.

Authors:  Joseph J Mazza; Steven H Yale; Jodi R Arrowood; Cory E Reynolds; Ingrid Glurich; Po-Huang Chyou; James G Linneman; Kurt D Reed
Journal:  Clin Med Res       Date:  2005-11

Review 5.  Pathogenicity of highly pathogenic avian influenza virus in mammals.

Authors:  Emmie de Wit; Yoshihiro Kawaoka; Menno D de Jong; Ron A M Fouchier
Journal:  Vaccine       Date:  2008-09-12       Impact factor: 3.641

Review 6.  Oseltamivir in human avian influenza infection.

Authors:  James R Smith
Journal:  J Antimicrob Chemother       Date:  2010-04       Impact factor: 5.790

7.  Structures of receptor complexes of a North American H7N2 influenza hemagglutinin with a loop deletion in the receptor binding site.

Authors:  Hua Yang; Li-Mei Chen; Paul J Carney; Ruben O Donis; James Stevens
Journal:  PLoS Pathog       Date:  2010-09-02       Impact factor: 6.823

8.  Determining the Seasonality of Respiratory Syncytial Virus in the United States: The Impact of Increased Molecular Testing.

Authors:  Claire M Midgley; Amber K Haynes; Jason L Baumgardner; Christina Chommanard; Sara W Demas; Mila M Prill; Glen R Abedi; Aaron T Curns; John T Watson; Susan I Gerber
Journal:  J Infect Dis       Date:  2017-08-01       Impact factor: 5.226

Review 9.  Past, present, and possible future human infection with influenza virus A subtype H7.

Authors:  Jessica A Belser; Carolyn B Bridges; Jacqueline M Katz; Terrence M Tumpey
Journal:  Emerg Infect Dis       Date:  2009-06       Impact factor: 6.883

10.  Partial direct contact transmission in ferrets of a mallard H7N3 influenza virus with typical avian-like receptor specificity.

Authors:  Haichen Song; Hongquan Wan; Yonas Araya; Daniel R Perez
Journal:  Virol J       Date:  2009-08-14       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.